Abstract
The development of new delivery systems for the controlled release of drugs is one of the most interesting fields of research in pharmaceutical sciences. Microparticles can be used for the controlled release of drugs, vaccines, antibiotics, and hormones. To prevent the loss of encapsulated materials, the microcapsules should be coated with another polymer that forms a membrane on the surface. In addition there are several fundamental properties of polymers that are useful in solving drug delivery problems, as they can be combined with the drug covalently or ionically to overcome problems like solubility, stability or permeability. Chitosan is a copolymer of N-acetylglucosamine and glucosamine derived from chitin, which is extracted from crustaceans ’ shells. This polymer has become the focus of major interest in recent years because it has applications in several fields such as biomedicine, agriculture, the textile industry and the paper industry. There are many processes that can be used to encapsulate drugs within chitosan matrixes such as ionotropic gelation, spray drying, emulsification- solvent evaporation and coacervation. Combinations of these processes are also used in order to obtain microparticles with specific properties and performances. This review provides an overview of these four techniques applied directly to chitosan microparticulate systems.
Keywords: Chitosan, controlled release systems, ionotropic gelation, spray drying, emulsification- solvent evaporation, coacervation
Current Drug Discovery Technologies
Title: New Drug Delivery Systems Based on Chitosan
Volume: 5 Issue: 4
Author(s): Ines Panos, Niuris Acosta and Angeles Heras
Affiliation:
Keywords: Chitosan, controlled release systems, ionotropic gelation, spray drying, emulsification- solvent evaporation, coacervation
Abstract: The development of new delivery systems for the controlled release of drugs is one of the most interesting fields of research in pharmaceutical sciences. Microparticles can be used for the controlled release of drugs, vaccines, antibiotics, and hormones. To prevent the loss of encapsulated materials, the microcapsules should be coated with another polymer that forms a membrane on the surface. In addition there are several fundamental properties of polymers that are useful in solving drug delivery problems, as they can be combined with the drug covalently or ionically to overcome problems like solubility, stability or permeability. Chitosan is a copolymer of N-acetylglucosamine and glucosamine derived from chitin, which is extracted from crustaceans ’ shells. This polymer has become the focus of major interest in recent years because it has applications in several fields such as biomedicine, agriculture, the textile industry and the paper industry. There are many processes that can be used to encapsulate drugs within chitosan matrixes such as ionotropic gelation, spray drying, emulsification- solvent evaporation and coacervation. Combinations of these processes are also used in order to obtain microparticles with specific properties and performances. This review provides an overview of these four techniques applied directly to chitosan microparticulate systems.
Export Options
About this article
Cite this article as:
Panos Ines, Acosta Niuris and Heras Angeles, New Drug Delivery Systems Based on Chitosan, Current Drug Discovery Technologies 2008; 5 (4) . https://dx.doi.org/10.2174/157016308786733528
DOI https://dx.doi.org/10.2174/157016308786733528 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Discrepancy between Gross Features and Chemical Compositions in
Gallbladder Stone: A Descriptive Single Center Study in the United Arab
Emirates
New Emirates Medical Journal The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story
Current Neuropharmacology The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer
Current Medicinal Chemistry Unique Challenges of Type 1 Diabetes in the Preschool Population
Current Diabetes Reviews Arterial Spin Labeling Perfusion MRI in Alzheimers Disease
Current Medical Imaging Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology Diet, Cardiometabolic Factors and Type-2 Diabetes Mellitus: The Role of Genetics
Current Diabetes Reviews Relevance of Sphingolipids in the Pleiotropic Protective Effects of High-Density Lipoproteins
Current Pharmaceutical Design Inhibition of Matrix Metalloproteinases as a Feasible Therapeutic Target in Rheumatoid Arthritis
Current Rheumatology Reviews Hypoglycemic Hemiparesis Masquerading As Ischemic Stroke: When Guideline Fails
Current Drug Therapy Comprehensive Review on Diabetes Associated Cardiovascular Complications - The Vitamin D Perspective
Cardiovascular & Hematological Disorders-Drug Targets Network Effect of Wt-mutant p53 Interactions and Implications on p53 Gene Therapy
Current Pharmaceutical Design ABC Transporters and Sterol Absorption
Current Drug Targets - Cardiovascular & Hematological Disorders Dietary Compounds, Epigenetic Modifications and Metabolic Diseases
Current Chemical Biology Phosphorylated and O-GlcNAc Modified IRS-1 (Ser1101) and -2 (Ser1149) Contribute to Human Diabetes Type II
Protein & Peptide Letters Tetrahydrobiopterin Pathway may Provide Novel Molecular Targets for Acute and Long Term Efficacy of Mood-Regulating Drugs
Current Pharmacogenomics and Personalized Medicine Hyperpolarized Metabolic MR in the Study of Cardiac Function and Disease
Current Pharmaceutical Design Hotspot Mutations in DICER1 Causing GLOW Syndrome-Associated Macrocephaly <i>via</i> Modulation of Specific microRNA Populations Result in the Activation of PI3K/ATK/mTOR Signaling
MicroRNA Correlation between Serum 25 hydroxy vitamin D level and plasminogen activator inhibitor 1 in type 2 diabetic patients
Endocrine, Metabolic & Immune Disorders - Drug Targets The Innate Immune System and Fever under Redox Control: A Narrative Review
Current Medicinal Chemistry